LobbyingRecordati Rare Diseases lobbying by quarter
Recordati Rare Diseases's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Recordati Rare Diseases
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $180K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 0 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$60K · 3 reports
- Medicare and Medicaid$60K · 3 reports
- Trade$60K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Arnold & Porter Kaye Scholer | $180K | 3 quarters |
| Connect 4 Strategies | $0 | 1 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Arnold & Porter Kaye Scholer | $60K |
| 04/17for Q1 | Arnold & Porter Kaye Scholer | $60K |
| 01/14for Q4 2025 | Arnold & Porter Kaye Scholer | $60K |
| 25/11/14for Q4 2025 | Arnold & Porter Kaye Scholer | Under $5,000 |
| 23/01/20for Q4 2022 | Connect 4 Strategies | Under $5,000 |